258 related articles for article (PubMed ID: 30735177)
21. Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues.
Hernandez S; Rojas F; Laberiano C; Lazcano R; Wistuba I; Parra ER
Front Mol Biosci; 2021; 8():667067. PubMed ID: 33996912
[TBL] [Abstract][Full Text] [Related]
22. Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.
Akturk G; Sweeney R; Remark R; Merad M; Gnjatic S
Methods Mol Biol; 2020; 2055():497-519. PubMed ID: 31502167
[TBL] [Abstract][Full Text] [Related]
23. The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
Taube JM; Akturk G; Angelo M; Engle EL; Gnjatic S; Greenbaum S; Greenwald NF; Hedvat CV; Hollmann TJ; Juco J; Parra ER; Rebelatto MC; Rimm DL; Rodriguez-Canales J; Schalper KA; Stack EC; Ferreira CS; Korski K; Lako A; Rodig SJ; Schenck E; Steele KE; Surace MJ; Tetzlaff MT; von Loga K; Wistuba II; Bifulco CB;
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414858
[TBL] [Abstract][Full Text] [Related]
24. A 40-Marker Panel for High Dimensional Characterization of Cancer Immune Microenvironments by Imaging Mass Cytometry.
Ijsselsteijn ME; van der Breggen R; Farina Sarasqueta A; Koning F; de Miranda NFCC
Front Immunol; 2019; 10():2534. PubMed ID: 31736961
[TBL] [Abstract][Full Text] [Related]
25. Optimising multiplex immunofluorescence staining for characterising the tumour immune micro-environment.
Cohen R; Lee-Pullen T; Miller TJ; Meehan K; Fuller K; McCoy MJ
Methods; 2023 Nov; 219():48-57. PubMed ID: 37741563
[TBL] [Abstract][Full Text] [Related]
26. The InSituPlex
Manesse M; Patel KK; Bobrow M; Downing SR
Methods Mol Biol; 2020; 2055():585-592. PubMed ID: 31502170
[TBL] [Abstract][Full Text] [Related]
27. Mixed Multiplex Staining: Automated RNAscope™ and OPAL™ for Multiple Targets.
Millar M
Methods Mol Biol; 2020; 2148():277-298. PubMed ID: 32394389
[TBL] [Abstract][Full Text] [Related]
28. Multiplex Fluorescent Immunohistochemistry for Preservation of Tumor Microenvironment Architecture and Spatial Relationship of Cells in Tumor Tissues.
McGue JJ; Edwards JJ; Griffith BD; Frankel TL
Methods Mol Biol; 2023; 2660():235-246. PubMed ID: 37191801
[TBL] [Abstract][Full Text] [Related]
29. Procedural Requirements and Recommendations for Multiplex Immunofluorescence Tyramide Signal Amplification Assays to Support Translational Oncology Studies.
Parra ER; Jiang M; Solis L; Mino B; Laberiano C; Hernandez S; Gite S; Verma A; Tetzlaff M; Haymaker C; Tamegnon A; Rodriguez-Canales J; Hoyd C; Bernachez C; Wistuba I
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31972974
[TBL] [Abstract][Full Text] [Related]
30. Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue.
Sachdeva A; Hart CA; Carey CD; Vincent AE; Greaves LC; Heer R; Oliveira P; Brown MD; Clarke NW; Turnbull DM
Sci Rep; 2022 Apr; 12(1):6660. PubMed ID: 35459777
[TBL] [Abstract][Full Text] [Related]
31. Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning system.
Anyaegbu CC; Lee-Pullen TF; Miller TJ; Abel TN; Platell CF; McCoy MJ
J Immunol Methods; 2019 Sep; 472():25-34. PubMed ID: 31181211
[TBL] [Abstract][Full Text] [Related]
32. A novel, automated technology for multiplex biomarker imaging and application to breast cancer.
Clarke GM; Zubovits JT; Shaikh KA; Wang D; Dinn SR; Corwin AD; Santamaria-Pang A; Li Q; Nofech-Mozes S; Liu K; Pang Z; Filkins RJ; Yaffe MJ
Histopathology; 2014 Jan; 64(2):242-55. PubMed ID: 24330149
[TBL] [Abstract][Full Text] [Related]
33. Immunofluorescence Labeling of Nuclear Receptor Expression in Formalin-Fixed, Paraffin-Embedded Tissue.
Lightbody ED; Nicol CJB
Methods Mol Biol; 2019; 1966():101-105. PubMed ID: 31041741
[TBL] [Abstract][Full Text] [Related]
34. Gene expression analysis in formalin fixed paraffin embedded melanomas is associated with density of corresponding immune cells in those tissues.
Kwak M; Erdag G; Slingluff CL
Sci Rep; 2020 Oct; 10(1):18336. PubMed ID: 33110110
[TBL] [Abstract][Full Text] [Related]
35. Using Immunohistochemistry Without Linkers to Determine the Optimum Concentrations of Primary Antibodies for Immunofluorescence Staining of Formalin-fixed Paraffin-embedded Tissue Sections.
Lugos MD; Davou GI; Choji TPP; Jugu KP; Ashi RR; Oyero SK; Perikala V
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):249-257. PubMed ID: 32197004
[TBL] [Abstract][Full Text] [Related]
36. Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging.
Du Z; Lin JR; Rashid R; Maliga Z; Wang S; Aster JC; Izar B; Sorger PK; Santagata S
Nat Protoc; 2019 Oct; 14(10):2900-2930. PubMed ID: 31534232
[TBL] [Abstract][Full Text] [Related]
37. Comparison of immunohistochemistry and immunofluorescence techniques using anti-lambda light chain antibodies for identification of immune complex deposits in canine renal biopsies.
Wong A; Cianciolo RE
J Vet Diagn Invest; 2018 Sep; 30(5):721-727. PubMed ID: 30027830
[TBL] [Abstract][Full Text] [Related]
38. Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists.
Harms PW; Frankel TL; Moutafi M; Rao A; Rimm DL; Taube JM; Thomas D; Chan MP; Pantanowitz L
Mod Pathol; 2023 Jul; 36(7):100197. PubMed ID: 37105494
[TBL] [Abstract][Full Text] [Related]
39. Multiplex immunofluorescence staining and image analysis assay for diffuse large B cell lymphoma.
Lee CW; Ren YJ; Marella M; Wang M; Hartke J; Couto SS
J Immunol Methods; 2020 Mar; 478():112714. PubMed ID: 31783023
[TBL] [Abstract][Full Text] [Related]
40. Multiplex Immunochromogenic Tissue Staining Employing Primary Antibodies from the Same Species.
Levin M; AkhavanAghdam Z; Schwartz D
Methods Mol Biol; 2023; 2593():127-142. PubMed ID: 36513928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
